| Kelli Jo Evans, PHD, CCC-SLP | |
|
5721 Usa North Dr, Hahn 1119, Mobile, AL 36688-0002 | |
| (251) 445-9378 | |
| (251) 445-9377 |
| Full Name | Kelli Jo Evans |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5721 Usa North Dr, Mobile, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013218809 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2865 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelli Jo Evans, PHD, CCC-SLP Po Box 40010, Mobile, AL 36640-0010 Ph: (251) 445-9378 | Kelli Jo Evans, PHD, CCC-SLP 5721 Usa North Dr, Hahn 1119, Mobile, AL 36688-0002 Ph: (251) 445-9378 |
News Archive
In ruling on the constitutionality of requiring most Americans to obtain health insurance, the Supreme Court faces a central test: whether it will recognize limits on its own authority to overturn well-founded acts of Congress.
SCHOTT introduced its adaptiQ™ system for ready-to-use pharmaceutical vials, which allows for more flexible manufacturing concepts and more efficient filling. Designed in close collaboration with filling line manufacturers to meet the pharmaceutical industry's process requirements, SCHOTT adaptiQ consists of a patented nest that securely holds as many as 100 clean and sterile vials in an industry standard tub.
Researchers have used next generation sequencing to trace the source and explain the spread of the latest (seventh) cholera pandemic. They have also highlighted the impact of the acquisition of resistance to antibiotics on shaping outbreaks and show resistance was first acquired around 1982.
A Ugandan drug trial's findings that the AIDS medication nevirapine is effective and safe in preventing HIV transmission from mother to unborn child during birth were well-supported, according to a new, independent analysis by the Institute of Medicine of the National Academies.
Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to extend the maturity date of Emisphere's Convertible Promissory Note (the "Note") to February 26, 2010.
› Verified 7 days ago
Reach Pediatric Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12485 Jeff Hamilton Rd, Mobile, AL 36695 Phone: 251-259-2430 | |
Rebecca Black, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Somerby Dr, Mobile, AL 36695 Phone: 251-633-4447 Fax: 251-633-4141 | |
Kimberley Meyer Warner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7158 Wynnridge Dr, Mobile, AL 36695 Phone: 251-634-4974 | |
Cheryl Pugh, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4720 Morrison Dr, Mobile, AL 36609 Phone: 877-787-3422 | |
Rebecca Clara Eskridge, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 C East Portier Ct., Mobile, AL 36607 Phone: 251-605-1334 | |
Victoria Rhea Childs, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1504 Spring Hill Ave, Mobile, AL 36604 Phone: 251-219-3923 Fax: 251-219-3750 |